Global Scar Treatment Market Analysis and Growth Report 2015-2019

Scars are treated using both invasive techniques such as surgery and non-invasive techniques such as OTC treatment products. These products and procedures are used to treat all types of scars, such as keloid scars, contracture scars, hypertrophic scars, and atrophic scars. Scars caused by surgery can be removed by surgical revisions, although most people are reluctant to go for another invasive procedure after a surgery. Apart from the easily available OTC scar treatment products, patients can also opt for less-known alternatives such as cryotherapy, clinical peel, and compression.

Analysts forecast the Global Scar Treatment market to grow at a CAGR of 9.09 percent over the period 2014-2019.

The Global Scar Treatment market can be divided into the following segments based on application: Burn Scars, Post-Surgical Scars, Other than Burn Scars, and Others.

Global Scar Treatment Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the US, Europe, and the ROW; it also covers the Global Scar Treatment market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Europe
  • ROW
  • US

Key Vendors

  • Avita Medical
  • CCA Industries
  • Enaltus
  • Merz Pharmaceuticals
  • Oculus Innovative Sciences
  • Pacific World
  • Revitol
  • Scarguard Labs
  • Suneva Medical
  • Valeant Pharmaceuticals International

Other Prominent Vendors

  • Absolute MS
  • Allergan
  • Avocet Polymer Technologies
  • Biodermis
  • Menarini Asia-Pacific
  • NewMedical Technology
  • Senvie

Key Market Driver

  • Increased Emphasis on Beauty

Key Market Challenge

  • Risks Associated with Scar Treatment Products

Key Market Trend

  • Increased Use of Silicone-based Products

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Have any Query on the Report get your Queries Resolved at .

(Prices start at US $2500 for a single user PDF)



Related Reports

Global Preventable Vaccines Market 2015-2019

Vaccines can be defined as a product that stimulates a person's immune system to produce immunity to a specific disease, thereby protecting the person from that disease. According to the CDC, vaccines are usually administered through needle injections, but can also be administered orally or sprayed into the nose. Vaccines can be used for both adults and infants and adolescents. Pediatric vaccines are used for the immunization of children to give protection against various infectious diseases such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases. According to the classification adopted by the US FDA, children are classified as newborn, infant, and adolescent, ranging from birth to 21 years of age.

Cystic Fibrosis Market in Europe 2015-2019

Cystic fibrosis, also known as mucoviscidosis, is a genetically inherited disease. The primary symptoms of cystic fibrosis include high salt content in the sweat, breathing difficulties, secretion of abnormally viscous mucus, respiratory complications, difficulties related to digestion, and growth anomalies. Cystic fibrosis is one of the most common genetic disorders observed in Caucasian children. Rare diseases are those that affect less than 5 patients per 10,000, as defined in the EU by Rare Disease UK.